Nehme Gerges Melhem is the founding President and Group Executive Chairman of Melhem Holdings, Inc. His work sits at the convergence of applied artificial intelligence, global health infrastructure, and institutional strategy — driven by a long-term mandate to build the systems that define how populations access care and how institutions respond to the challenges of a complex world.
His leadership agenda spans multiple geographies and sectors: from the design of national digital health systems in the Middle East to precision health initiatives in the Gulf, and capacity building programs across the African continent. He has cultivated a portfolio of academic relationships with leading institutions across North America and the Middle East — grounded in a commitment to research-driven, institutionally disciplined execution.
Under his direction, Melhem Holdings has established itself not as a consultancy or advisory firm, but as an operational platform — one that takes ownership of the systems it builds, the intellectual property it generates, and the long-term partnerships it cultivates.
A senior executive within the Melhem Holdings platform, bringing strategic leadership and operational depth to the organization's expanding global mandate. Works in close alignment with the President & Group Executive Chairman to advance the platform's institutional relationships and execution agenda.
Leads global operations across the Melhem Holdings platform — overseeing the execution infrastructure that enables the organization to deliver on its commitments across multiple geographies and sectors. Mandate spans operational strategy, cross-entity coordination, and international presence.
Leads operational and philanthropic initiatives across the Melhem Holdings platform, overseeing the integration of institutional programs with the Foundation's humanitarian and capacity-building mandate. Brings a cross-functional perspective that connects day-to-day operations with long-term impact.
Leads Melhem Pharmaceuticals with a mandate focused on pharmaceutical access, clinical integration, and distribution infrastructure across priority markets in the Middle East, Africa, and North America. Brings deep expertise in pharmaceutical strategy and health systems to the platform's most operationally complex subsidiary.
Manages Melhem Scientific's portfolio of global academic and institutional partnerships, driving strategic development and collaborative research engagement across the organization's international network. Plays a central role in connecting the platform's scientific agenda with real-world institutional alignment.
Drives business strategy and development for Melhem Pharmaceuticals, overseeing commercial planning, market positioning, and the strategic frameworks that guide the entity's growth across pharmaceutical access markets. Brings a rigorous analytical perspective to the organization's most commercially active subsidiary.
A researcher of international standing in molecular neuro-oncology and translational biomedical sciences. His work at the intersection of basic science and clinical application makes his advisory role central to the scientific credibility and research integrity of the platform.
A leading academic neurologist and clinical researcher whose career spans translational neuroscience, epilepsy, and clinical systems design. His institutional standing across major academic medical centers brings clinical depth and research credibility that directly informs the scientific integrity of the platform.
Engagement with Melhem Holdings leadership is reserved for partners, institutions, and organizations whose objectives align with the platform's mission and long-term direction.